Asymptomatic Moyamoya Disease

Satoshi Kuroda

doi:10.1007/978-981-33-6404-2_12

Asymptomatic Moyamoya Disease

Satoshi Kuroda^*

^*Corresponding author for this work

Neurosurgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

Original language	English
Title of host publication	Moyamoya Disease
Subtitle of host publication	Current Knowledge and Future Perspectives
Publisher	Springer Singapore
Pages	143-152
Number of pages	10
ISBN (Electronic)	9789813364042
ISBN (Print)	9789813364035
DOIs	https://doi.org/10.1007/978-981-33-6404-2_12
State	Published - 2021/01/01

Keywords

Asymptomatic moyamoya disease
Cerebral blood flow
Cerebral infarct
Microbleed
Multicenter observational study
Outcome
Risk
Stroke

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-981-33-6404-2_12

Cite this

@inbook{80ca88999df2436ca2458517733aad78,

title = "Asymptomatic Moyamoya Disease",

abstract = "The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.",

keywords = "Asymptomatic moyamoya disease, Cerebral blood flow, Cerebral infarct, Microbleed, Multicenter observational study, Outcome, Risk, Stroke",

author = "Satoshi Kuroda",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-981-33-6404-2_12",

language = "英語",

isbn = "9789813364035",

pages = "143--152",

booktitle = "Moyamoya Disease",

publisher = "Springer Singapore",

}

TY - CHAP

T1 - Asymptomatic Moyamoya Disease

AU - Kuroda, Satoshi

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

AB - The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

KW - Asymptomatic moyamoya disease

KW - Cerebral blood flow

KW - Cerebral infarct

KW - Microbleed

KW - Multicenter observational study

KW - Outcome

KW - Risk

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85134525340&partnerID=8YFLogxK

U2 - 10.1007/978-981-33-6404-2_12

DO - 10.1007/978-981-33-6404-2_12

M3 - 章

AN - SCOPUS:85134525340

SN - 9789813364035

SP - 143

EP - 152

BT - Moyamoya Disease

PB - Springer Singapore

ER -

Asymptomatic Moyamoya Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this